sponsored by:

Cell & Gene Therapies Coming to Self-Insured Health Plans Near You
Emerging cell and gene therapies offer great promise to patients in need of better treatment options, but these therapies often have significant financial implications for employer sponsors of self-insured group health plans along with their stop-loss partners. This session will preview the most likely treatments that may come to market over the next 12-24 months and discuss coverage and financing considerations that will need to be addressed…sooner than most self-insurance industry stakeholders realize today.

Speakers:

David McLean, PhD
CEO
Emerging Therapy Solutions/LifeTrac

Jay Ritchie
President
Tokio Marine HCC - Stop Loss Group

Surya Singh, MD
Former Vice President and Chief Medical Officer, Specialty Pharmacy
CVS Health

Date: May 6, 2021, 2:00 - 3:00 pm EDT

Cost: No charge for both SIIA Members and non-members